Mei‐Chun Cai

2.0k total citations
40 papers, 1.0k citations indexed

About

Mei‐Chun Cai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Mei‐Chun Cai has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Mei‐Chun Cai's work include Nonlinear Dynamics and Pattern Formation (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Mei‐Chun Cai is often cited by papers focused on Nonlinear Dynamics and Pattern Formation (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Mei‐Chun Cai collaborates with scholars based in China, United States and Hong Kong. Mei‐Chun Cai's co-authors include Guanglei Zhuang, Pengfei Ma, Shengzhe Zhang, Zhi‐Liang Ji, Ying Jing, Jie Wu, Yujie Fu, Xiaojing Zhao, Minjiang Chen and Wen Di and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Mei‐Chun Cai

39 papers receiving 1.0k citations

Peers

Mei‐Chun Cai
Heonjong Han South Korea
Dabin Jeong South Korea
Eunbeen Kim South Korea
Hyeon-Nae Jeon South Korea
Nicholas C. Spies United States
Adam Coffman United States
Heonjong Han South Korea
Mei‐Chun Cai
Citations per year, relative to Mei‐Chun Cai Mei‐Chun Cai (= 1×) peers Heonjong Han

Countries citing papers authored by Mei‐Chun Cai

Since Specialization
Citations

This map shows the geographic impact of Mei‐Chun Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Chun Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Chun Cai more than expected).

Fields of papers citing papers by Mei‐Chun Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Chun Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Chun Cai. The network helps show where Mei‐Chun Cai may publish in the future.

Co-authorship network of co-authors of Mei‐Chun Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Chun Cai. A scholar is included among the top collaborators of Mei‐Chun Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Chun Cai. Mei‐Chun Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Mei‐Chun, Jin Liu, Pengfei Ma, et al.. (2024). YY1 downregulation underlies therapeutic response to molecular targeted agents. Cell Death and Disease. 15(11). 862–862. 3 indexed citations
2.
Cai, Mei‐Chun, Di Jin, Tianxiang Zhang, et al.. (2024). Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer. Clinical Cancer Research. 30(21). 4920–4931. 1 indexed citations
3.
Xiang, Huaijiang, Zhenfeng Zhang, Mei‐Chun Cai, et al.. (2023). Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer. Science Advances. 9(47). eadj0123–eadj0123. 9 indexed citations
4.
Cheng, Lin, Kaixuan Shi, Yan Cheng, et al.. (2022). Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer. Cancer Research. 82(19). 3588–3602. 25 indexed citations
5.
Shi, Kaixuan, Haijiao Lu, Zhenfeng Zhang, et al.. (2022). Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer. Cell Death and Differentiation. 30(1). 195–207. 7 indexed citations
6.
Shi, Kaixuan, Mei‐Chun Cai, Caiyan Zhang, et al.. (2022). SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer. Oncogene. 41(12). 1767–1779. 13 indexed citations
7.
Zhang, Ruiyun, Feng Xie, Yue Zhang, et al.. (2021). Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer. The Journal of Urology. 206(4). 873–884. 36 indexed citations
8.
Jia, Chenqiang, Zhuqing Zhang, Jun Tang, et al.. (2021). Epithelial-Mesenchymal Transition Induces GSDME Transcriptional Activation for Inflammatory Pyroptosis. Frontiers in Cell and Developmental Biology. 9. 781365–781365. 13 indexed citations
9.
Zhang, Yi, Minhua Yu, Ying Jing, et al.. (2020). Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer. British Journal of Cancer. 124(2). 414–424. 50 indexed citations
10.
Yin, Xia, Rui Bi, Pengfei Ma, et al.. (2019). Multiregion whole-genome sequencing depicts intratumour heterogeneity and punctuated evolution in ovarian clear cell carcinoma. Journal of Medical Genetics. 57(9). 605–609. 13 indexed citations
11.
Lu, Haijiao, Shengzhe Zhang, Jie Wu, et al.. (2018). Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death. Clinical Cancer Research. 24(23). 6066–6077. 204 indexed citations
12.
Zhang, Zhenfeng, Huixin Peng, Xiaojie Wang, et al.. (2017). Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer. Molecular Cancer Therapeutics. 16(9). 1739–1750. 58 indexed citations
13.
Yin, Xia, Ying Jing, Mei‐Chun Cai, et al.. (2017). Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer. Cancer Research. 77(23). 6551–6561. 23 indexed citations
14.
Ma, Pengfei, Yujie Fu, Mei‐Chun Cai, et al.. (2017). Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer. Nature Communications. 8(1). 823–823. 49 indexed citations
15.
Gao, Xiang, Feifei Zheng, Mei‐Chun Cai, et al.. (2016). Phase-locked scroll waves defy turbulence induced by negative filament tension. Physical review. E. 93(1). 12216–12216. 10 indexed citations
16.
Pan, Jianbo, et al.. (2016). Pattern Genes Suggest Functional Connectivity of Organs. Scientific Reports. 6(1). 26501–26501. 11 indexed citations
17.
Zhang, Zhenfeng, Pengfei Ma, Ying Jing, et al.. (2015). BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1. Theranostics. 6(2). 219–230. 81 indexed citations
18.
Cai, Mei‐Chun, et al.. (2014). ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms. Nucleic Acids Research. 43(D1). D907–D913. 72 indexed citations
19.
Cai, Mei‐Chun, et al.. (2014). Core solutions of rigidly rotating spiral waves in highly excitable media. Physical Review E. 89(2). 22920–22920. 4 indexed citations
20.
Pan, Jianbo, et al.. (2013). PaGenBase: A Pattern Gene Database for the Global and Dynamic Understanding of Gene Function. PLoS ONE. 8(12). e80747–e80747. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026